Molecular Profiling
186 articles
RNA Precision Trial for Pancreatic Cancer Opens At Columbia
Dr. Andrea Califano leads a precision oncology clinical trial of the OncoTreat platform, which looks at proteins to determine treatment.
Will New-Onset Diabetes Provide a Way to Detect Pancreatic Cancer Earlier?
Dr. Anirban Maitra, Dr. Suresh Chari, and others are looking at the relationship between new-onset diabetes and pancreatic cancer.
The American Association for Cancer Research (AACR) Virtual Special Conference: Pancreatic Cancer Day One
Let’s Win and the Lustgarten Foundation present highlights of Day One of the AACR Virtual Special Conference on Pancreatic Cancer.
A Report from ASCO GI 2022
Clinical trials were reported on at ASCO GI 2022, as well as reports on COVID, virtual tumor boards, and racial disparities in treatment.
Lustgarten–AACR Name Career Development Award Winners
The Lustgarten Foundation and AACR announced the winners of the 2022 Ruth Bader Ginsburg and John Robert Lewis Career Development Awards.
Meet the Researcher: Jeffrey Patterson-Fortin, M.D., Ph.D.
Researcher Dr. Jeffrey Patterson-Fortin focuses on DNA damage repair as he looks for better pancreatic cancer treatments.
AI Platform Reveals Hidden Biology of Tumor Formation
Dr. Laura Wood and colleagues are developing an artificial intelligence (AI) platform to identify tumors as they are forming.
New Prospective Clinical Study of Blood-Based Early Detection Test
Dr. Rosalie Sears is working with Biological Dynamics to test a new early detection blood assay and platform for pancreatic cancer screening.
Adapting Chemotherapy Regimens for a Better Pancreatic Cancer Outcome
Researchers are comparing chemotherapy regimens for effectiveness before surgery, and whether switching treatments makes a difference.
ASCO 2023: Pancreatic Cancer Research Update
The pancreatic cancer research reports from ASCO 2023 focused on different chemotherapy combinations, including immunotherapy.
A Long Slog to Diagnosis, A Quick Sprint to Surgery
Joseph Mele suffered through a year of mysterious GI symptoms until he was finally diagnosed with stage II pancreatic cancer.
Understanding How Super-Enhancers Rev Up Pancreatic Cancer Growth
Researcher Ronald Evans, Ph.D., and his team at the Salk Institute are focusing on how super-enhancers stimulate pancreatic cancer growth.
Steely Strength to Keep Going
Long-term survivor Davi D’Agostino discovered she carries the BRCA2 mutation, which changed her treatment plan to targeted therapy.
Don’t Give Up
Joe Pearson responded so well to chemotherapy that even with a stage III tumor near a blood vessel he was able to have Whipple surgery.
ASCO GI Symposium Features a Broad Range of Pancreatic Cancer Research
Researchers at ASCO GI 2024 reported on research in health disparities, KRAS and other genetic mutations, and novel treatments.